InvestorsHub Logo
Followers 0
Posts 147
Boards Moderated 0
Alias Born 12/08/2004

Re: None

Monday, 01/22/2018 1:29:11 PM

Monday, January 22, 2018 1:29:11 PM

Post# of 2432
Latest letter from sec on there september S-1 filing.
You can look it up yourself. If they had a problem the SEC would not send this letter.
https://www.sec.gov/Archives/edgar/data/1438943/000000000017035911/0000000000-17-035911-index.htm Mail Stop 3561
Via E-mail
Robert Brooke
Chief Executive Officer
Vitality Biopharma, Inc.
1901 Avenue of the Stars, 2nd Floor Los Angeles, California 90067
Re: Vitality Biopharma, Inc. Registration Statement on Form S-1 FiledSeptember13,2017
File No. 333-220446
Dear Mr. Brooke:
October 10, 2017
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Michael Killoy at (202) 551-7576 with any questions.
cc: Mark C. Lee, Esq. Greenberg Traurig, LLP
Sincerely,
/s/ James Lopez (for)
John Reynolds
Assistant Director
Office of Beverages, Apparel, and Mining